Benchmark Holdings shared its Q3 results showing fifth consecutive quarter of year-on-year and quarter-on-quarter growth.

“Q3 represents a continuation of the operational and financial progress reported consistently by Benchmark over the quarters following the 2020 restructuring. We continue our dedicated work to realize the potential of the well-invested and well-positioned platform that Benchmark has become,” Trond Williksen, CEO of Benchmark, said.

“We are excited about the development of a new configuration and business model for CleanTreat®, which although reducing our growth rate for next year, increases our confidence in the solution and enhances Benchmark’s long-term prospects,” he continued. “Overall, we expect to continue to deliver further underlying progress in the coming quarters, with the aim of becoming a profitable company supporting the global aquaculture industry with sustainable solutions.”

Advanced Nutrition

Advanced Nutrition continued good performance driven by commercial focus and cost discipline with good resilience to inflationary environments through better productivity and asset utilization.

Advanced Nutrition revenues were up 5% with all product areas aided by favorable forex rates in the period, with CER revenues decreasing 5% due to the timing of orders. By product area, sales of Artemia were +8%, diets +1% and health +6% higher than Q3 2021.

The business area continues to perform strongly with good visibility to the end of the year, the company said. In the YTD, all sales regions were up in the prior year except China, and overall, conditions in the shrimp markets are positive.